home / stock / zlab / zlab news


ZLAB News and Press, Zai Lab Limited

Stock Information

Company Name: Zai Lab Limited
Stock Symbol: ZLAB
Market: NASDAQ
Website: zailaboratory.com

Menu

ZLAB ZLAB Quote ZLAB Short ZLAB News ZLAB Articles ZLAB Message Board
Get ZLAB Alerts

News, Short Squeeze, Breakout and More Instantly...

ZLAB - Zai Lab outlines 2026 transition year with multiple late-stage catalysts and targets first global approval by 2028

2026-02-26 13:48:42 ET More on Zai Lab Zai Lab Limited (ZLAB) Q4 2025 Earnings Call Transcript Zai Lab Limited (ZLAB) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript Zai Lab Limited (ZLAB) Presents at 44th Annual J.P. Morgan Healthcare Conferenc...

ZLAB - Zai Lab Limited (ZLAB) Q4 2025 Earnings Call Transcript

2026-02-26 13:47:55 ET Zai Lab Limited (ZLAB) Q4 2025 Earnings Call February 26, 2026 8:00 AM EST Company Participants Christine Chiou - Senior VP & Head of Investor Relations Ying Du - Founder, Chairperson & CEO Rafael Amado - President and Head of Global ...

ZLAB - Zai Lab GAAP EPS of -$0.05 beats by $0.30, revenue of $127.6M beats by $4.93M

2026-02-26 07:12:31 ET More on Zai Lab Zai Lab Limited (ZLAB) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript Zai Lab Limited (ZLAB) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Zai Lab Limited (ZLAB) Presents at 44th An...

ZLAB - Zai Lab Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates

– Total revenues grew 17% y-o-y to $127.6 million for the fourth quarter of 2025 and 15% y-o-y to $460.2 million for the full-year 2025 – Zocilurtatug pelitecan (zoci) on track to become Zai Lab’s first global oncology launch, with three registration-enabling studie...

ZLAB - Expected US Company Earnings on Thursday, February 26th, 2026

Evertec Inc. (EVTC) is expected to report $0.81 for Q4 2025 BioCryst Pharmaceuticals Inc. (BCRX) is expected to report $0.06 for Q4 2025 FTI Consulting Inc. (FCN) is expected to report $1.38 for Q4 2025 Arbe Robotics Ltd. (ARBE) is expected to report $-0.1 for Q4 2025 Aclaris Ther...

ZLAB - Zai Lab Q4 2025 Earnings Preview

2026-02-25 12:18:49 ET More on Zai Lab Zai Lab Limited (ZLAB) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript Zai Lab Limited (ZLAB) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Zai Lab Limited (ZLAB) Presents at 44th An...

ZLAB - Baron Emerging Markets Fund Q4 2025 Portfolio Activity

2026-02-22 13:56:00 ET ... Read the full article on Seeking Alpha For further details see: Baron Emerging Markets Fund Q4 2025 Portfolio Activity

ZLAB - Zai Lab Limited (ZLAB) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript

2026-02-20 16:44:57 ET Zai Lab Limited (ZLAB) Citi's 2026 Virtual Oncology Leadership Summit February 19, 2026 2:30 PM EST... Read the full article on Seeking Alpha For further details see: Zai Lab Limited (ZLAB) Presents at Citi's 2026 Virtual Oncology Leadership Summit Tra...

ZLAB - Zai Lab to Announce Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates on February 26, 2026

- Company to host conference call and webcast on February 26, 2026, at 8:00 a.m. ET (9:00 p.m. HKT) Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report its fourth quarter and full year 2025 financial results and provide recent corporate updates on Febr...

ZLAB - NovoCure projects $13M monthly revenue hit as Medicare revokes billing privileges

2026-02-05 10:03:48 ET More on NovoCure NovoCure Limited (NVCR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Why NovoCure Is Failing To Disrupt NSCLC NovoCure: 2026 Pipeline Outlook Makes This Stock A Speculative Buy Novocure reports F...

Next 10